The poor prognosis of advanced metastatic differentiated thyroid cancer (DTC) is primarily due to reduced expression of the sodium/iodide symporter (NIS) or decreased targeting of NIS to the cell membrane, which reduces the efficacy of radioactive iodine therapy[158]. The gene discussed is SLC5A5; the disease is differentiated thyroid carcinoma.